Kyle Konze

Title: Innovations by Kyle Konze in Drug Discovery

Introduction

Kyle Konze is an innovative inventor based in New York, NY (US). He has made significant contributions to the field of drug discovery through his patented methods. His work focuses on predicting active sets of compounds that can effectively bind to biomolecular targets.

Latest Patents

Kyle Konze holds a patent titled "Methods for predicting an active set of compounds having alternative cores, and drug discovery methods involving the same." This patent describes a system, device, and method for predicting an active set of compounds that bind to a biomolecular target. The system includes various modules that facilitate the prediction process. A core identification module identifies the core of an initial lead compound. A core hopping module identifies potential lead compounds with different cores. A scoring module calculates the relative binding free energy of each identified potential lead compound. Finally, an activity prediction module uses these calculations to predict an active set of compounds that bind to the biomolecular target. Empirical analysis is employed to enhance the accuracy and completeness of the predicted active set of compounds.

Career Highlights

Kyle Konze is currently associated with Schrödinger, Inc., where he continues to advance his research in drug discovery. His innovative approach has garnered attention in the scientific community, contributing to the development of new methodologies in the field.

Collaborations

Some of his notable coworkers include Robert L. Abel and Lingle Wang, who is a prominent female scientist in the industry. Their collaborative efforts have further enriched the research environment at Schrödinger, Inc.

Conclusion

Kyle Konze's contributions to drug discovery through his innovative patent demonstrate his commitment to advancing scientific knowledge. His work not only enhances the understanding of compound interactions but also paves the way for future developments in the field.